| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
| LINC01221 |
|
long intergenic non-protein coding RNA 1221
|
|
|
1.000 |
0.038 |
| TMEM72-AS1 |
|
TMEM72 antisense RNA 1
|
|
|
|
|
| GMDS-DT |
|
GMDS divergent transcript
|
|
|
0.861 |
0.077 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| LINC01752 |
|
long intergenic non-protein coding RNA 1752
|
|
|
|
|
| PIK3IP1-AS1 |
|
PIK3IP1 antisense RNA 1 (head to head)
|
|
|
|
|
| OSMR-AS1 |
|
OSMR antisense RNA 1 (head to head)
|
|
|
1.000 |
0.077 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| CTXND2 |
A0A1B0GV90
|
cortexin domain containing 2
|
|
|
1.000 |
0.038 |
| HBZP1 |
|
hemoglobin subunit zeta pseudogene 1
|
|
|
|
|
| HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
| LINC01993 |
|
long intergenic non-protein coding RNA 1993
|
|
|
|
|
| LINC00877 |
|
long intergenic non-protein coding RNA 877
|
|
|
|
|
| LINC01222 |
|
long intergenic non-protein coding RNA 1222
|
|
|
|
|
| TTC25 |
Q96NG3
|
tetratricopeptide repeat domain 25
|
|
|
0.674 |
0.538 |
| DNAH10 |
Q8IVF4
|
dynein axonemal heavy chain 10
|
Enzyme
|
1.4E-57 |
0.890 |
0.154 |
| LAMA3 |
Q16787
|
laminin subunit alpha 3
|
Enzyme modulator
|
8.8E-46 |
0.576 |
0.731 |
| THADA |
Q6YHU6
|
THADA armadillo repeat containing
|
Receptor
|
4.6E-41 |
0.686 |
0.500 |
| SLC22A16 |
Q86VW1
|
solute carrier family 22 member 16
|
Transporter
|
6.3E-27 |
0.626 |
0.500 |